Teva- Pharmaceutical Industries Ltd
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.
Current Price
$35.73
-0.78%GoodMoat Value
$21.98
38.5% overvaluedProfile
Valuation (TTM)
Market Cap$41.08B
P/E26.27
EV—
P/B5.19
Shares Out1.15B
P/Sales2.37
Revenue$17.35B
EV/EBITDA16.43
Teva- Pharmaceutical Industries Ltd (TEVA) Stock News
TEVA Stock News & Headlines
Latest stock news and headlines for Teva- Pharmaceutical Industries Ltd (TEVA). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $35.73. Market cap: $41.08B. Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. This page aggregates the latest news articles relevant to TEVA from financial news sources, helping investors stay current on events that may impact Teva- Pharmaceutical Industries Ltd's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Teva- Pharmaceutical Industries Ltd (TEVA).